非洲儿童和青少年血压升高患病率:系统综述与Meta分析
该系统综述与Meta分析检索1996年1月1日至2017年2月2日发表的研究,纳入51项研究进行定性合成、25项进入Meta分析,共54 196名2-19岁参与者。血压升高(收缩压或舒张压≥第95百分位)的合并患病率为5.5%(95%CI 4.2-6.9),肥胖儿童血压升高患病率为30.8%(95%CI 20.1-42.6),约为正常体重儿童(5.5%,95%CI 3.1-8.4)的六倍(p<0.0001)。
要点
- 非洲儿童和青少年血压升高合并患病率为5.5%(95%CI 4.2-6.9)。
- 肥胖儿童血压升高患病率30.8%,约为正常体重儿童(5.5%)的六倍(p<0.0001)。
- 作者建议主要通过社区层面促进健康生活方式的一级预防来应对,并强调需采用统一可靠的诊断方法开展更精细研究。
核心结论
- 本研究提示非洲儿童和青少年血压升高患病率较高,超重和肥胖是重要危险因素。
- 作者建议应对该负担的努力主要聚焦于社区层面的一级预防,通过促进健康生活方式和避免其他心血管危险因素,尤其是超重和肥胖。
- 作者还强调需要采用统一可靠的诊断方法开展更精细的研究,以可靠地描绘非洲儿童和青少年血压升高的负担。
研究设计与样本
- 系统综述与Meta分析,检索Embase、PubMed、African Journals Online和African Index Medicus,纳入1996年1月1日至2017年2月2日发表的文章,并检索所获文章的参考文献列表。
- 每项研究独立进行方法学质量评价;采用随机效应模型估计血压升高患病率,通过Cochran Q统计量的χ2检验评估异质性(I²)。
- 共纳入51项研究进行定性合成,25项进入Meta分析,报告54 196名2-19岁参与者的合并样本数据;研究质量高,仅4项中等质量研究,无低质量研究。
- 本综述在PROSPERO注册,注册号CRD42015019029。
主要发现
- 血压升高患病率在研究间差异很大(范围0.2%-24.8%)。
- 血压升高(收缩压或舒张压≥第95百分位)的合并患病率为5.5%(95%CI 4.2-6.9)。
- 轻度血压升高(收缩压或舒张压≥第90百分位且<第95百分位)的合并患病率为12.7%(95%CI 2.1-30.4)。
- 血压升高患病率在很大程度上与体重指数(BMI)相关,肥胖儿童血压升高患病率为30.8%(95%CI 20.1-42.6),正常体重儿童为5.5%(95%CI 3.1-8.4),肥胖儿童约为正常体重儿童的六倍(p<0.0001)。
临床怎么用
- 作者认为应对非洲儿童和青少年血压升高负担的努力应主要聚焦于社区层面的一级预防,通过促进健康生活方式和避免其他心血管危险因素,尤其是超重和肥胖。
- 作者强调需要采用统一可靠的诊断方法开展更精细的研究,以可靠地描绘非洲儿童和青少年血压升高的负担。
局限性
- 作者指出需要采用统一可靠的诊断方法开展更精细的研究,以可靠地描绘非洲儿童和青少年血压升高的负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite substantial attention paid to the threat of elevated blood pressure in children and adolescents in high-income countries and the epidemic of hypertension in African adult populations, data on the burden of elevated blood pressure in African children and adolescents have not yet been synthesised. We did a systematic review and meta-analysis to provide estimates of the prevalence of elevated blood pressure and assess associated factors among children and adolescents in Africa. METHODS: We searched Embase, PubMed, African Journals Online, and African Index Medicus to identify articles published from Jan 1, 1996, to Feb 2, 2017, and searched the reference list of retrieved articles. Each study was independently reviewed for methodological quality. We used a random-effects model to estimate the prevalence of elevated blood pressure across studies and heterogeneity (I2) was assessed via the χ2 test on Cochran's Q statistic. This review is registered with PROSPERO, number CRD42015019029. FINDINGS: We included 51 studies in qualitative synthesis and 25 in the meta-analysis reporting data of a pooled sample of 54 196 participants aged 2-19 years. Study quality was high with only four medium-quality studies and no low-quality studies. Prevalence of elevated blood pressure varied widely across studies (range 0·2-24·8%). The pooled prevalence of elevated blood pressure (systolic or diastolic blood pressure ≥95th percentile) was 5·5% (95% CI 4·2-6·9), whereas that of slightly elevated blood pressure (systolic or diastolic blood pressure ≥90th percentile and <95th percentile) was 12·7% (2·1-30·4). The prevalence of elevated blood pressure was largely associated with body-mass index (BMI), with a prevalence of elevated blood pressure six times higher in obese (30·8%, 95% CI 20·1-42·6) versus normal-weight children (5·5%, 3·1-8·4; p<0·0001). INTERPRETATION: This study suggests a high prevalence of elevated blood pressure among children and adolescents in Africa, with overweight and obesity being an important risk factor. Efforts to address this burden of elevated blood pressure in children and adolescents should mainly focus on primary prevention at the community level, by promoting healthy lifestyles and avoiding other cardiovascular risk factors, especially overweight and obesity. This study also stresses the need for more elaborate studies using uniform and reliable diagnostic methods to reliably map the burden of elevated blood pressure in children and adolescents in Africa. FUNDING: None.
引用
- Noubiap JJ, Essouma M, Bigna JJ, et al. Prevalence of elevated blood pressure in children and adolescents in Africa: a systematic review and meta-analysis. Lancet Public Health. 2017. PMID: 29253478. doi:10.1016/S2468-2667(17)30123-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。